KINGTON CAPITAL
Founded in 2016, Kington Capital is supported by the Suzhou municipal government. Kington is the first municipal private investment platform engaged in direct investment and fund management focusing on four industries: capital- and technology-intensive manufacturing, brand driven consumption, high-end medical health, and next generation information technology.
Similar Organizations
Hengying Capital
Hengying Capital is a private equity investment fund management company.
South China Venture Capital
South China Venture Capital is a private equity investment fund management firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-13 | Qixin Micro Semiconductor | Kington Capital investment in Series B - Qixin Micro Semiconductor | N/A |
| 2022-03-01 | EVAS Intelligence | Kington Capital investment in Seed Round - EVAS Intelligence | 200 M CNY |
| 2021-04-22 | Next Generation Gene Therapeutics | Kington Capital investment in Series A - Next Generation Gene Therapeutics | 30 M USD |
| 2019-02-25 | Gracell Biotechnologies | Kington Capital investment in Series B - Gracell Biotechnologies | 85 M USD |
| 2019-01-29 | LanssonPharm | Kington Capital investment in Series A - LanssonPharm | 2.97 M USD |
| 2018-11-26 | Kanova | Kington Capital investment in Series A - Kanova | 115 M CNY |
| 2018-11-12 | SyMap Medical | Kington Capital investment in Series C - SyMap Medical | 70 M CNY |
| 2018-08-20 | RiVAI | Kington Capital investment in Angel Round - RiVAI | 2.94 M CNY |
| 2018-03-07 | JW Therapeutics | Kington Capital investment in Series A - JW Therapeutics | 90 M USD |
| 2018-02-02 | SmartNuclide | Kington Capital investment in Series A - SmartNuclide | 10 M CNY |